Around the nation: Kaiser Permanente pledges up to $1.65M to support California wildfire relief efforts

Bite-sized hospital and health industry news

Kaiser Permanente said it will donate up to $1.65 million for relief and recovery efforts for victims of the California wildfires, up to $1 million of which will go to the American Red Cross and other community- and faith-based organizations, in today's bite-sized hospital and health industry news from California, Iowa, and New York.

  • California: Kaiser Permanente said it will donate up to $1.65 million for relief and recovery efforts for victims of the California wildfires, up to $1 million of which will go to the American Red Cross and other community- and faith-based organizations. Kaiser also will donate $500,000 to the United Way of Greater Los Angeles for relief efforts serving low-income residents (Gooch, Becker's Hospital & CFO Report, 12/4).

  • Iowa: Finley Hospital in Dubuque has named Chad Wolbers as president and CEO, effective Jan. 21, 2019. Wolbers most recently worked as a consultant and account leader at Studer Group. He's also served as Finley's COO and as president and CEO of Keokuk County Health Center in Sigourney (Vaidya, Becker's Hospital Review, 12/4).

  • New York: Mount Sinai Health System has finalized a partnership with South Nassau Communities Hospital, under which Sinai will invest $120 million to establish South Nassau as its flagship hospital on Long Island. According to Becker's Hospital Review, the partnership will help the hospitals provide a number of services, including clinical trials, to patients in Long Island who otherwise would have had to travel for care (Vartorella, Becker's Hospital Review, 12/5).

4 strategies to surpass monumental fundraising goals

The reality of today’s campaigns calls for new strategies to meet the elevated demands of both health systems and donors. This infographic is your guide to four essential strategies to maximize campaign performance.

Download Now


Next in the Daily Briefing

Can your DNA reveal how you'll respond to antidepressants? Experts are skeptical (but one company is forging ahead anyway).

Read now